111C Judy, Kevin - Thomas Jefferson University - Thomas Jefferson University
Kevin D. Judy, MD

Kevin D. Judy, MD

Contact Dr. Judy

909 Walnut St
Philadelphia, Pennsylvania 19107

(215) 503-0524
(215) 503-9357 fax

Most Recent Peer-reviewed Publications

  1. BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial
  2. Tumor volume threshold for achieving improved conformity in VMAT and Gamma Knife stereotactic radiosurgery for vestibular schwannoma
  3. Vorinostat as a radiosensitizer for brain metastasis: A phase i clinical trial
  4. Cryptococcal ventriculoperitoneal shunt infection
  5. Cancer of the Central Nervous System
  6. < 16D0 a href="http://syndic8.scopus.com/action/redirectFile?&zone=main¤tActivity=feed&usageType=outward&url=http%3A%2F%2Fwww.scopus.com%2Finward%2Frecord.url%3Feid%3D2-s2.0-80051790121%26rel%3DR4.0.0%26partnerID%3D35%26md5%3D5bd21e36495396bb8c6a536b099dd3ef" target="_blank">Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: Age, cochlear dose, and tumor coverage
  7. Clinically silent somatotroph adenomas are common
  8. Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging
  9. Biodistribution and dosimetry of 18F-EF5 in cancer patients with preliminary comparison of 18F-EF5 uptake versus EF5 binding in human glioblastoma
  10. Concurrent cochlear implantation with resection of skull base hemangiopericytoma following sudden deafness in an only hearing ear
  11. Poor drug distribution as a possible explanation for the results of the PRECISE trial
  12. The relationship among hypoxia, proliferation, and outcome in patients with de nouo glioblastoma: A pilot study
  13. Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas: Clinical investigative study
  14. Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status
  15. Hypoxia in brain tumors: A review of the literature
  16. Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging
  17. Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors
  18. A phase I trial of ad.hIFN-β gene therapy for glioma
  19. Arterial spin-labeling and MR spectroscopy in the differentiation of gliomas
  20. Prediction of oligodendro 016A glial tumor subtype and grade using perfusion weighted magnetic resonance imaging